CDiddy, I concur with you. Nader was terminat
Post# of 148155
I concur with you. Nader was terminated for a good reason, nominally or otherwise.
The title of the announcement read:
CytoDyn Announces Leadership Transition Plan to Support Regulatory Approval and Commercialization of Leronlimab
And, SK commented:
Scott A. Kelly, M.D, Chairman of the Board and Chief Medical Officer of CytoDyn, stated, “Now is the right time for the next phase of CytoDyn’s evolution, as we focus on continuing the clinical progress of leronlimab and ultimately securing regulatory approval and commercialization.
Of course, all of the above are just "nice" words but we, the investors, who have been supporting the company all this time through very difficult times should be informed, one way or another, of the why's and how's. Why was he fired ??? and how is this the right time for the next phase (sans Nader)?
Maybe something is on the works that require full silence, maybe not. But they can easily say: we aren't talking because we can't. A 10 seconds proactive with Christine will do , there is a lot of meat in the BBQ and we, the investors, just can't be given the "mushroom treatment" for much longer.
I hope there is a PR soon.